Results 301 to 310 of about 7,134,173 (343)
Some of the next articles are maybe not open access.
Cost-effectiveness in health and medicine
, 20161. Cost-Effectiveness Analysis as a Guide to Resource Allocation in Health: Roles and Limitations 2. Theoretical Foundations of Cost-Effectiveness Analysis 3. Framing and Designing the Cost-Effectiveness Analysis 4.
M. Gold
semanticscholar +2 more sources
The International Encyclopedia of Higher Education Systems and Institutions, 2020
in
Elisabeth Oehrlein+92 more
semanticscholar +1 more source
in
Elisabeth Oehrlein+92 more
semanticscholar +1 more source
Cost Effects of Restricting Cost-effective Therapy
Medical Care, 1985This article examines the cost effects of a closed pharmaceutical formulary on Medicaid expenditures for peptic ulcer disease. Studies were performed before and after the imposition of a closed pharmaceutical formulary and indicated that total Medicaid costs for peptic ulcer treatment were 15.0% lower during the closed formulary than open formulary ...
Bernard S. Bloom, Jake Jacobs
openaire +2 more sources
Journal of Studies on Alcohol and Drugs, 2018
OBJECTIVE Evidence on the comparative cost-effectiveness of alcohol control strategies is a relevant input into public policy and resource allocation. At the global level, this evidence has been used to identify so-called best buys for noncommunicable ...
D. Chisholm+6 more
semanticscholar +1 more source
OBJECTIVE Evidence on the comparative cost-effectiveness of alcohol control strategies is a relevant input into public policy and resource allocation. At the global level, this evidence has been used to identify so-called best buys for noncommunicable ...
D. Chisholm+6 more
semanticscholar +1 more source
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
New England Journal of Medicine, 2014The ratio of $50,000 per quality-adjusted life-year (QALY) gained by using a given health care intervention has long served as a benchmark for the value of U.S. health care.
P. Neumann+2 more
semanticscholar +1 more source
2000
A Medline search for cost-effectiveness in the ICU documents the importance attributed to the issue.
Reis Miranda, D., Jegers, Marc
openaire +4 more sources
A Medline search for cost-effectiveness in the ICU documents the importance attributed to the issue.
Reis Miranda, D., Jegers, Marc
openaire +4 more sources
Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review.
Diabetes Technology & Therapeutics, 2018BACKGROUND Telemedicine has been utilized increasingly worldwide for diabetes management, due to its potential to improve healthcare access and clinical outcomes.
J. Lee, Shaun Wen Huey Lee
semanticscholar +1 more source
2018
If VADs and ECMO are to become part of routine care, they need to demonstrate that they are cost-effective. Otherwise, the time and money they consume would be better spent elsewhere in the health system. A cost-effective therapy is one that provides value for money in terms of the healthy life years gained for the costs incurred.
Barnsbee, Louise+3 more
openaire +3 more sources
If VADs and ECMO are to become part of routine care, they need to demonstrate that they are cost-effective. Otherwise, the time and money they consume would be better spent elsewhere in the health system. A cost-effective therapy is one that provides value for money in terms of the healthy life years gained for the costs incurred.
Barnsbee, Louise+3 more
openaire +3 more sources
Current Opinion in Lipidology, 2000
The efficacy of lipid-lowering with statins has become clear. Indirect estimations, and direct measurements from long-term randomized trials have also demonstrated cost-effectiveness, both in secondary and primary prevention of coronary heart disease. Targeting care efficiently to high-risk groups by calculating absolute risk is essential.
openaire +3 more sources
The efficacy of lipid-lowering with statins has become clear. Indirect estimations, and direct measurements from long-term randomized trials have also demonstrated cost-effectiveness, both in secondary and primary prevention of coronary heart disease. Targeting care efficiently to high-risk groups by calculating absolute risk is essential.
openaire +3 more sources
The American Journal of Cardiology, 1998
Currently, 6 hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are marketed in the United States (US). Given the wide variation in the prices and efficacy of statins, formal cost-effectiveness analysis may improve drug selection decisions.
Dale F. Kraemer+6 more
openaire +3 more sources
Currently, 6 hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are marketed in the United States (US). Given the wide variation in the prices and efficacy of statins, formal cost-effectiveness analysis may improve drug selection decisions.
Dale F. Kraemer+6 more
openaire +3 more sources